This article has been updated to reflect the increased size of a study by Inova.

NEW YORK (GenomeWeb News) − The Inova Translational Medicine Institute has teamed up with Personalis for the analysis and clinical interpretation of whole-genome sequencing data from patients with undiagnosed syndromes, the partners said today.

Under the collaboration, ITMI, a non-profit research institute that is part of the Inova Health System, will perform whole-genome sequencing on patients with suspected genetic disease who have not been able to obtain a molecular diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.